Biopharma Vision today announced that it had completed a comprehensive commercial review of the entire R&D portfolio for a client company in Andover, MA. On the behalf of client, Biopharma Vision conducted an extensive commercial assessment of 3 distinctive products in the areas of ENT (Ear, Nose & Throat). For each of the 3 products, Biopharma Vision assessed & analyzed a broad range of business issues, including technological feasibility, clinical needs, development risk & timeline, addressable market & commercial potential, regulatory strategy, pricing & reimbursement, financial projection & valuations.

Karl Qin, President of Biopharma Vision commented, " In the past several months, we had worked very closely with the senior management team of the client company & its SAB (Scientific Advisory Board) members in formulating and validating its R&D and commercial strategies. We are very pleased to assist our client to advance the company to a stage where the first clinical trial is currently underway. In addition, the company is well positioned to start Series B financing shortly.”

In concert with R&D portfolio review, Biopharma Vision also worked with the client company and participated in putting in place PPM (Private Placement of Memorandum) for its upcoming Series B financing, which is expected to raise a total of $14-20M

Biopharma Vision LLC is a management consulting firm specialized in providing business and commercial development services to life science companies. Based in Boston area, Massachusetts, the company was founded in 2007.

Biopharma Vision today announced that it had assisted a client in its effort of closing a Serious B financing. Biopharma Vision had been playing a critical role in helping the client to raise capital to bring its first product to the market within the next 24 months. Karl Qin, President of Biopharma Vision commented, "We are very pleased to have the opportunity in helping the client in this fund raising effort. We worked closely with the senior management of the client company in formulating and executing the private placement strategy, including the business plan, Private Placement Memorandum, and valuation and pricing.” Due to these collective efforts, the client has so far received 2 term sheets from several global investment groups, with a total proposed capital commitment of $15M.

Biopharma Vision LLC is a management consulting firm specialized in providing business and commercial development services to life science companies. Based in Boston area, Massachusetts, the company was founded in 2007.

Biopharma vision today announced that on behalf of its client based in Maynard, MA, it had successfully negotiated and assisted in entering into a licensing and distribution agreement with a premier Japanese life science company. The agreement allows the Japanese partner to immediately market and distribute the client's first proprietary product in cell based research and drug discovery in Japan. Karl Qin, President of Biopharma Vision commented, "we are excited to help our client bring in a leading Japanese life science company for their most important product. We are especially pleased that we were able to close the deal for our client in less than 2 months. This transaction clearly demonstrated our strong expertise and capabilities in helping our clients in executing its strategic alliance objectives".

Biopharma Vision today announced that it had signed on a Medford, MA based molecular diagnostic company as its third client. The company is developing innovative products in real-time clinical diagnostics. Karl Qin, President of Biopharma Vision commented, "we are very pleased to have the opportunity in helping the client in formulating and executing a broad range of business and commercial development strategies. Successful development of molecular diagnostics approves to be one of the critical elements in ultimate realization of the point-of-care diagnostics and personalized medicines". Biopharma Vision LLC is a management consulting firm specialized in providing business and commercial development services to life science companies. Based in Boston area, Massachusetts, the company was founded in September 2007